Biotechnology Innovation Organization

I Am Biotech is where biotech professionals and enthusiasts can come together and discuss the promise of biotech innovation. #Biotech

[Biotechnology Innovation Organization @IAmBiotech]

Driven By Purpose: Ahead of #BIO2026, Christina Hartman, Executive Director, Head of U.S. Government Affairs at @orchard_tx, is driven by hope for her daughter Charlotte - and the belief that continued advances in biotech can bring hope to children living with ultra-rare conditions. #BIO2026
Learn more and register: https://t.co/Fp2jdXnllw

[Biotechnology Innovation Organization @IAmBiotech]

The #FightOfOurLives often starts with a single moment. For Katy Grainger, one small, seemingly harmless moment changed everything. Within 36 hours, she was in septic shock - fighting for her life against an antibiotic-resistant infection.

Katy’s journey is deeply personal. And it’s a reminder of what it means to fight - the persistent push for new options, new treatments, and new answers for the fight ahead.

Watch Katy’s story and see how American biotech is transforming lives and delivering hope to millions: https://t.co/zvvwh8L8UO

[Biotechnology Innovation Organization @IAmBiotech]

Preparedness cannot be built during an emergency. In a new @statnews op-ed, W. Craig Vanderwagen and Jennifer B. Alton - architects of the original Pandemic and All-Hazards Preparedness Act - make the case for why Congress must reauthorize PAHPA now and confirm leadership at both ASPR and the CDC. Read more: https://t.co/sBDqOI0Xlq

[Biotechnology Innovation Organization @IAmBiotech]

A new analysis from @MagnoliaAccess warns the U.S. biopharmaceutical ecosystem is at risk, with projections showing up to a 55% decline in drugs reaching the market over the next 20 years. See how changes in research funding, regulatory uncertainty, and drug pricing policies could affect the future of drug development.

Read the report: “The U.S. Biopharmaceutical Innovation Ecosystem at Risk: The 20-Year Threat to U.S. Innovation and Cures.” https://t.co/zvru5h7mWp

[Biotechnology Innovation Organization @IAmBiotech]

Ahead of #BIO2026, we asked Chris Rofidal, Senior Director of Health Policy and Pipeline Strategy at @UTHRMed, what he's driven by: "I'm driven by innovation... we have to have innovative products to get to our patients to change lives, to save lives." Learn more: https://t.co/Fp2jdXnllw

[Biotechnology Innovation Organization @IAmBiotech]

Read more here: https://t.co/sXm4SZBhJQ

[Biotechnology Innovation Organization @IAmBiotech]

This week in https://t.co/ZpbgpvzkpL: Patient advocates, including the
@tigerlilycares, are praising @GovernorVA's veto of Prescription Drug Affordability Board (PDAB) legislation, marking the third time such a proposal has come before the Virginia Legislature in five years. BIO weighs in on what this decision means for the state and for patients: https://t.co/LcCABhOGhx

[Biotechnology Innovation Organization @IAmBiotech]

AI is transforming biotech - and the #BIO2026 AI Summit on Monday, June 22 is where industry tech experts will share real-world, concrete examples of how AI is being meaningfully implemented to accelerate drug discovery, improve R&D productivity, and enable new scientific approaches. Learn more: https://t.co/Fp2jdXnllw

[Biotechnology Innovation Organization @IAmBiotech]

Come to #BIO2026 with more than a badge - come with a calendar full of productive 1:1 meetings. BIO Partnering™ connects you to the people who can move your work forward. Start scheduling: https://t.co/8lvlSyDHVv

[Biotechnology Innovation Organization @IAmBiotech]

Michael Stocum, President and CEO of @bantampharma, is coming back to #BIO2026 to build on the relationships and progress made last year after participating in BIO Partnering™ - and to share what it means for the cancer patients his work will serve.

Learn more and register: https://t.co/Fp2jdXnllw

[Biotechnology Innovation Organization @IAmBiotech]

At BIO 2026, biotech innovators, partners, and advocates from around the globe will come together — united by an unwavering conviction to solve the impossible, push boundaries, and make lives better — because together, our industry and our mission are driven by purpose. #BIO2026 Register: https://t.co/Fp2jdXnllw

[Biotechnology Innovation Organization @IAmBiotech]

Tomorrow, June 11: BIO Senior Director of Patient Advocacy Karin Hoelzer is moderating a panel at the @OrphanConf in Boston on how industry, CMS, and patients can advance access to orphan drugs. The discussion will cover coverage pathways, evidence generation, and collaborative approaches to expanding access for rare disease patients. Learn more: https://t.co/wUvS5jnEQQ
#RareDisease #Biotech

[Biotechnology Innovation Organization @IAmBiotech]

As the June 12 onshoring plan deadline nears, uncertainty around Section 232 pharmaceutical tariffs continues to pose real challenges for biotech innovators.

What do companies still need to know - and how could this shape the future of the industry? Read the latest from https://t.co/ZpbgpvyMAd:
https://t.co/lVjrH58T2K

#Biotech #BioInnovation

[Biotechnology Innovation Organization @IAmBiotech]

Tomorrow at 12 PM ET, join BIO and the @NatPress for a free webinar on vaccine policy for health journalists. Claim your seat: https://t.co/BmZ17mUA1O #Vaccines #BiotechInnovation

[Biotechnology Innovation Organization @IAmBiotech]

Hear from Audrey Greenberg, @MayoClinic Venture Partner & Chair of the Department of Business Development, on what BIO Partnering™ has meant to her work and the broader ecosystem – from therapeutics and diagnostics to enabling platforms and digital health. #BIO2026 is just around the corner. Learn more and register: https://t.co/Fp2jdXnllw

[Biotechnology Innovation Organization @IAmBiotech]

The #BIO2026 Exhibit Hall is your chance to discover leading biotech companies and the latest innovations across the industry. Browse the Exhibitor Directory and plan your visit today.

https://t.co/Yg4Zypp6ug

[Biotechnology Innovation Organization @IAmBiotech]

In a June 4 House hearing on medicines and patent policy, lawmakers weighed in on the role of IP protections in driving biotech innovation. Read the latest on https://t.co/9hOxRo6BPd: https://t.co/4G13Oh7zWy
#IP #Biotech

[Biotechnology Innovation Organization @IAmBiotech]

At #BIO2026, we’re bringing lessons in leadership from the field to the main stage. Join @Marcus_Freeman1, Head Football Coach at the University of @NotreDame, as he kicks off Tuesday’s program with an inspiring fireside chat moderated by BIO President & CEO John F. Crowley. Widely respected for his intentional leadership style - blending determination, resolve, and an unmistakable competitive edge - Coach Freeman will draw on powerful lessons in leadership and resilience, exploring what it truly means to be “Driven by Purpose.” Learn more: https://t.co/Fp2jdXnllw